[1]
|
H. H. Li and L. Ma, “Studies on the Antibacterial Effect of Chinese Medicinal Plants,” Journal of Changchun University of Traditional Chinese Medicine, Vol. 26, No. 1, 2010, pp. 136-137.
|
[2]
|
H. G. Liu, Q. R. Shen and L. M. Liu, “The Development of Traditional Chinese Medicine in Antibacteria,” Lishizhen Medicine and Materia Medica Research, Vol. 21, No. 2, 2010, pp. 463-465.
|
[3]
|
Z. P. Gou and D. G. Wan, “Antibacterial Activity of Varieties of Flos Lonicerae Produced in Sichuan in Vitro by Beating Holes Method,” Lishizhen Medicine and Materia Medica Research, Vol. 19, No. 3, 2008, pp. 724-725.
|
[4]
|
Y. B. Tian, Z. H. Chen, M. H. Yang, Y. L. Hu, Q. L. Liu and L. Z. Liu, “In Vitro Bacteriostatic Investigation of 16 Chinese Medical Formula Decoction on MRSA and MSSA,” Chinese Journal of Hospital Pharmacy, No. 11, 2009, pp. 897-899.
|
[5]
|
Y. J. Yang, Y. Q. Liu, J. F. Zhang, X. H. Huang, F. Tan, H. X. Cai, H. P. Huang and Y. Zhu, “In Vitro Antibacterial Activity of Coptidis rhizoma and Galla chinensis on VRE,” Journal of Southern Medical University, No. 5, 2008, pp. 819-820.
|
[6]
|
M. J. Chen, G. Li, L. Gu, J. Liu and S. H. Xiao, “Study on Antibacterial Effect of YINHUANG Injection in Vitro,” Lishizhen Medicine and Materia Medica Research, Vol. 18, No. 2, pp. 377-378.
|
[7]
|
F. Liu and M. R. Kong, “Overview of Antibacterial Activities of Traditional Chinese Medicine,” Chinese Journal of Ethnomedicine and Ethnopharmacy, Vol. 2, No. 19, 2010, pp. 14, 38.
|
[8]
|
J. J. Champoux, “DNA Topoisomerases: Structure, Function, and Mechanism,” Annual Review of Biochemistry, Vol. 70, 2001, pp. 369-413.
doi:10.1146/annurev.biochem.70.1.369
|
[9]
|
R. J. Reece and A. Maxwell, “DNA Gyrase: Structure and Function,” Critical Reviews in Biochemistry and Molecular Biology, Vol. 26, No. 3-4, 1991, pp. 335-375.
doi:10.3109/10409239109114072
|
[10]
|
K. Drlica and M. Malik, “Fluoroquinolones: Action and Resistance,” Current Topics in Medicinal Chemistry, Vol. 3, No. 3, 2003, pp. 249-282.
doi:10.2174/1568026033452537
|
[11]
|
A. Maxwell, “DNA Gyrase as a Drug Target,” Biochemical Society Transactions, Vol. 27, No. 2, 1999, pp. 4853.
|
[12]
|
M. Chatterji, S. Unniraman, S. Mahadevan and V. Nagaraja, “Effect of Different Classes of Inhibitors on DNA Gyrase from Mycobacterium smegmatis,” Journal of Antimicrobial Chemotherapy, Vol. 48, No. 4, 2001, pp. 479-485. doi:10.1093/jac/48.4.479
|
[13]
|
Chinese Pharmacopoeia Commission, “Pharmacopoeia of the People’s Republic of China (Volume I),” People’s Medical Publishing House, Beijing, 2010.
|
[14]
|
T. M. Zhang, “Chinese Medica Materia,” Higher Education Press, Beijing, 2008.
|